west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "王立夫" 3 results
  • STUDIES ON ENHANCEMENT OF TRANSVERSE RECTUS ABDOMINIS MUSCULOCUTANEOUS FLAP SURVIVAL BY RECOMBINANT ADENOVIRUS MEDIATED VASCULAR ENDOTHELIAL GRWOTH FACTOR 165 GENE

    Objective To investigate the enhancement of the transverse rectusabdominis musculocutaneous (TRAM) flap survival in local ischemic area by recombinant adenovirus mediated vascular endothelial growth factor 165 gene(Ad-VEGF-165). Methods The vascular pedicle TRAM flaps were made in the right abdomin of30 SD rats and they were randomly divided into 5 groups. The Ad-VEGF-165 was injected into the subcutaneous tissue of epigastra(group 1), the subcutaneous tissue of epigastria and rectus abdominis muscle (group 2), and the rectus abdominis muscle(group 3); Adenovirus mediated green fluorescent protein(Ad-GFP) and DMEMwere injected into the subcutaneous tissue of epigastria and rectus abdominis muscle as autocontrol(group 4) and blank control(group 5), respectively. The survival areas of TRAM flap was measured after 7 days of operation. The microvascular density(MVD) and the integral optical density (IOD) were tested with anti-rat CD34 and with VEGF immunohistochemistry and insitu hybridization histochemistry (ISHH), respectively. Results The survivalareas of TRAM flap in groups 1, 2 and 3 (14.19±2.77, 15.18±2.18 and 8.30±1.28 cm2) were higher than those in groups 4 and 5(4.12±186 and 3.60±1.95 cm2), being significant differences(Plt;0.05).The CD34 MVD of the TRAMflap in groups 1, 2 and 3 was higher than that in groups 4 and 5; the positiveexpression for VEGF and ISHH were shown in groups 1, 2 and 3 and there was significant difference when compared with groups 4 and 5 (Plt;0.05). Conclusion Treatment by recombinant Ad-VEGF165gene is an effective option for enhancement of the TRAM flap survival in the local ischemic area.

    Release date:2016-09-01 09:30 Export PDF Favorites Scan
  • 腓肠肌肌瓣修复小腿胫前中上段感染性软组织缺损

    目的 总结应用腓肠肌肌瓣修复小腿胫前中上段感染性软组织缺损的疗效。 方法2007年4月-2011年7月,收治11例胫骨开放性骨折固定术后并发胫前中上段感染性软组织缺损患者。男8例,女3例;年龄12~86岁,中位年龄34岁。交通事故伤9例,重物砸伤2例。于骨折固定术后7~12 d 出现创面软组织坏死、感染,细菌培养均呈阳性。伤后至此次入院时间为7~15 d,平均12 d。软组织缺损范围8 cm × 6 cm~16 cm × 10 cm。术中切取大小为11 cm × 7 cm~19 cm × 11 cm的腓肠肌肌瓣修复软组织缺损合并胫骨外露或骨髓腔,大腿中厚皮片覆盖肌瓣表面。 供瓣区间断缝合。 结果术后腓肠肌肌瓣及皮片均成活,供、受区创面Ⅰ期愈合。患者均获随访,随访时间6~57个月,平均21个月。受区外形饱满,皮片柔软、耐磨,无溃疡形成。X线片检查示骨折均愈合,愈合时间5~13个月。 结论腓肠肌肌瓣是修复小腿胫前中上段感染性软组织缺损的有效方法之一,具有血循环可靠、肌肉组织量丰富、切取简便、供区损伤小、并发症少等优点。

    Release date:2016-08-31 04:21 Export PDF Favorites Scan
  • Application of the Vacuum-assisted Closure Therapy on Pressure Dressing in Free Transplant Operation for Free Split-Thickness Skin Graft on Anterior Thoracic Wall, Abdominal Wall and Back

    目的 探讨应用负压辅助愈合治疗系统(V.A.C. Therapy)在胸、腹、背部断层皮片游离移植术后加压固定的有效性。 方法 2010年10月-2011年10月,应用V.A.C. Therapy加压固定游离断层皮片修复21例胸、腹、背部皮肤软组织缺损患者。男15例,女6例;年龄21~63岁,平均43岁。其中瘢痕切除后创面13例,皮瓣切取后供瓣区形成的创面8例。创面位于胸部7例,腹部9例,背部5例。皮肤及软组织缺损范围12 cm×10 cm~18 cm×15 cm。游离移植的断层皮片厚度为0.6 mm,在缺损部位移植断层皮片后,使用V.A.C. Therapy固定皮片,压力范围100~125 mm Hg (1 mm Hg=0.133 kPa)。 结果 住院时间19~32 d,平均24 d。21例植皮均成活,受区创面Ⅰ期愈合;供皮区创面Ⅰ期愈合。随访时间6~12个月,平均8个月。游离移植皮肤色泽与周围皮肤色泽相似,无破溃,无明显凹陷。 结论 应用V.A.C. Therapy加压固定的游离断层皮片,成活率高,效果可靠,是一种安全实用的固定方法。

    Release date:2016-09-08 09:17 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content